101 related articles for article (PubMed ID: 8706889)
21. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
Siemeister G; Schirner M; Reusch P; Barleon B; Marmé D; Martiny-Baron G
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4625-9. PubMed ID: 9539788
[TBL] [Abstract][Full Text] [Related]
22. Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture.
Oyama T; Sakuta T; Matsushita K; Maruyama I; Nagaoka S; Torii M
J Periodontol; 2000 Oct; 71(10):1546-53. PubMed ID: 11063386
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression.
Heil M; Clauss M; Suzuki K; Buschmann IR; Willuweit A; Fischer S; Schaper W
Eur J Cell Biol; 2000 Nov; 79(11):850-7. PubMed ID: 11139149
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OM; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ
Am J Pathol; 1999 Apr; 154(4):1125-35. PubMed ID: 10233851
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of angiotensin-converting enzyme by tumor necrosis factor-alpha and interleukin-1beta in cultured human endothelial cells.
Saijonmaa O; Nyman T; Fyhrquist F
J Vasc Res; 2001; 38(4):370-8. PubMed ID: 11455208
[TBL] [Abstract][Full Text] [Related]
26. Roles of tumor necrosis factor p55 and p75 receptors in TNF-alpha-induced vascular permeability.
Ferrero E; Zocchi MR; Magni E; Panzeri MC; Curnis F; Rugarli C; Ferrero ME; Corti A
Am J Physiol Cell Physiol; 2001 Oct; 281(4):C1173-9. PubMed ID: 11546653
[TBL] [Abstract][Full Text] [Related]
27. Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells.
Paleolog EM; Delasalle SA; Buurman WA; Feldmann M
Blood; 1994 Oct; 84(8):2578-90. PubMed ID: 7919375
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells.
Patterson C; Perrella MA; Endege WO; Yoshizumi M; Lee ME; Haber E
J Clin Invest; 1996 Jul; 98(2):490-6. PubMed ID: 8755661
[TBL] [Abstract][Full Text] [Related]
29. Functional role of Egr-1 mediating VEGF-induced tissue factor expression in the retinal capillary endothelium.
Sassa Y; Hata Y; Murata T; Yamanaka I; Honda M; Hisatomi T; Fujisawa K; Sakamoto T; Kubota T; Nakagawa K; Sueishi K; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):1003-10. PubMed ID: 12483323
[TBL] [Abstract][Full Text] [Related]
30. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
Kirchhofer D; Tschopp TB; Hadváry P; Baumgartner HR
J Clin Invest; 1994 May; 93(5):2073-83. PubMed ID: 8182139
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor induces endothelial fenestrations in vitro.
Esser S; Wolburg K; Wolburg H; Breier G; Kurzchalia T; Risau W
J Cell Biol; 1998 Feb; 140(4):947-59. PubMed ID: 9472045
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1.
Mechtcheriakova D; Wlachos A; Holzmüller H; Binder BR; Hofer E
Blood; 1999 Jun; 93(11):3811-23. PubMed ID: 10339488
[TBL] [Abstract][Full Text] [Related]
33. Characterization of different soluble TNF receptor (TNFR80) derivatives: positive influence of the intracellular domain on receptor/ligand interaction and TNF neutralization capacity.
Moosmayer D; Wajant H; Gerlach E; Schmidt M; Brocks B; Pfizenmaier K
J Interferon Cytokine Res; 1996 Jun; 16(6):471-7. PubMed ID: 8807502
[TBL] [Abstract][Full Text] [Related]
34. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
Ahmed A; Dunk C; Kniss D; Wilkes M
Lab Invest; 1997 Jun; 76(6):779-91. PubMed ID: 9194854
[TBL] [Abstract][Full Text] [Related]
35. Effects of hyperthermia and tumour necrosis factor on inflammatory cytokine secretion and procoagulant activity in endothelial cells.
Gnant MF; Turner EM; Alexander HR
Cytokine; 2000 Apr; 12(4):339-47. PubMed ID: 10805214
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
Barleon B; Siemeister G; Martiny-Baron G; Weindel K; Herzog C; Marmé D
Cancer Res; 1997 Dec; 57(23):5421-5. PubMed ID: 9393770
[TBL] [Abstract][Full Text] [Related]
37. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
38. Induction of endothelial cell decay-accelerating factor by vascular endothelial growth factor: a mechanism for cytoprotection against complement-mediated injury during inflammatory angiogenesis.
Mason JC; Lidington EA; Yarwood H; Lublin DM; Haskard DO
Arthritis Rheum; 2001 Jan; 44(1):138-50. PubMed ID: 11212152
[TBL] [Abstract][Full Text] [Related]
39. Effect of FGF-1 and FGF-2 on VEGF binding to human umbilical vein endothelial cells.
Chen JH; Wang XC; Kan M; Sato JD
Cell Biol Int; 2001; 25(3):257-60. PubMed ID: 11352499
[TBL] [Abstract][Full Text] [Related]
40. TNF receptor signal transduction. Ligand-dependent stimulation of a serine protein kinase activity associated with (CD120a) TNFR60.
VanArsdale TL; Ware CF
J Immunol; 1994 Oct; 153(7):3043-50. PubMed ID: 8089485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
